| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_356aa1a0ebfce59b19d07b4d13953826 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4738 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4738
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 |
| filingDate |
2021-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ee23629d05fcfdabab30d4dd45b5108
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6d14b9d7df3c5ce92a8db0c65a4b5ccf |
| publicationDate |
2022-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20220146095-A |
| titleOfInvention |
Composition for prevention and treating dementia through the combination of PDE5 inhibitors and glucocorticoid receptor antagonists |
| abstract |
The present invention relates to mirodenafil, which is one of phosphodiesterase 5 inhibitors (PDE5 inhibitors), and CIORT-108297 (CORT-), which is one of Glucocorticoid Receptor (GR) Antagonists. 108297), and to its use as a therapeutic agent for Alzheimer's disease and dementia through the removal of amyloid beta. |
| priorityDate |
2021-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |